Health
Will a **therapeutic vaccine** for a chronic viral infection (e.g., HIV, HSV) successfully complete Phase 2 human trials by 2026?
Forecasting a major milestone in infectious disease treatment using next-generation vaccine technology.
Yes 60%Maybe 0%No 40%
5 total votes